Drugs / Meksibel
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04608760 Comparator | Aug 2020 → Jan 2021 | acute pancreatitis, cholangitis | Vitebsk State Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meksibel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04608760 ↗ |
| Route | Intravenous | “Intravenous 0.1 30 minutes before the procedure and 0.1 once a day for 3 days after the procedure” NCT04608760 ↗ |